Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval

Hengrui Pharma and Braveheart Bio report positive Phase 2 results for HRS/BHB-1893 in oHCM

Amgen reports Repatha (evolocumab) cuts risk of first major CV events by 31% in high-risk patients without known significant atherosclerosis

GE HealthCare's Photonova Spectra gains FDA clearance

IsomAb names new CEO

Nuwellis completes Rendiatech acquisition

HeartBeam and Mount Sinai partner to advance AI-enabled cardiac monitoring

Medicomp Systems client IJN in Malaysia granted Stage 7 validation from HIMSS EMRAM

Precision BioSciences receives FDA Fast Track designation for PBGENE-DMD

GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care

Esperion to acquire Corstasis, expanding cardiovascular portfolio

Circio reports up to 50-fold gene expression gain in eye for circVec-AAV platform

Celyad Oncology sells C-Cathez catheter to CellProthera

Realheart secures European patent for artificial heart technology

Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban